| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO transferase activity | 9.57e-06 | 36 | 160 | 5 | GO:0019789 | |
| GeneOntologyMolecularFunction | creatine kinase activity | 9.92e-06 | 6 | 160 | 3 | GO:0004111 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, nitrogenous group as acceptor | 2.75e-05 | 8 | 160 | 3 | GO:0016775 | |
| GeneOntologyMolecularFunction | small GTPase binding | 2.72e-04 | 321 | 160 | 10 | GO:0031267 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 3.51e-04 | 42 | 160 | 4 | GO:0071889 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 5.21e-04 | 20 | 160 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | GTPase binding | 6.67e-04 | 360 | 160 | 10 | GO:0051020 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CDHR5 CELSR2 PCDHGA12 PCDHGA8 | 2.01e-07 | 187 | 157 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | phosphocreatine metabolic process | 4.28e-06 | 5 | 157 | 3 | GO:0006603 | |
| GeneOntologyBiologicalProcess | phosphagen biosynthetic process | 4.28e-06 | 5 | 157 | 3 | GO:0042396 | |
| GeneOntologyBiologicalProcess | phosphocreatine biosynthetic process | 4.28e-06 | 5 | 157 | 3 | GO:0046314 | |
| GeneOntologyBiologicalProcess | phosphagen metabolic process | 4.28e-06 | 5 | 157 | 3 | GO:0006599 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.42e-05 | 20 | 157 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 2.15e-05 | 198 | 157 | 9 | GO:0048813 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | RGPD2 ING1 SUN1 DVL1 RGPD1 CARD10 NUP58 SIX4 TRIM28 RGPD3 AKAP1 RGPD5 | 2.22e-05 | 362 | 157 | 12 | GO:0034504 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CDHR5 CELSR2 PCDHGA12 PCDHGA8 | 2.89e-05 | 313 | 157 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 3.51e-05 | 9 | 157 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 4.99e-05 | 10 | 157 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | astral microtubule organization | 1.17e-04 | 13 | 157 | 3 | GO:0030953 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.17e-04 | 13 | 157 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | nonassociative learning | 1.17e-04 | 13 | 157 | 3 | GO:0046958 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.27e-04 | 195 | 157 | 8 | GO:0006606 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.48e-04 | 14 | 157 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | STRN3 ING1 RIPPLY2 ZBTB4 GATA2 PER1 POU5F1 RREB1 HDAC7 TBX18 ZNF469 SIRT2 ZNF296 MYOZ1 TRIM28 YLPM1 ZBTB10 PHF14 TCFL5 WDTC1 | 1.50e-04 | 1053 | 157 | 20 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | STRN3 RPS6KA5 ING1 RIPPLY2 ZBTB4 GATA2 PER1 POU5F1 SIX4 RREB1 HDAC7 FZD1 TBX18 ZNF469 SIRT2 ZNF296 MYOZ1 TRIM28 YLPM1 ZBTB10 SIX5 PHF14 TCFL5 WDTC1 | 1.50e-04 | 1399 | 157 | 24 | GO:0045892 |
| GeneOntologyBiologicalProcess | import into nucleus | 1.57e-04 | 201 | 157 | 8 | GO:0051170 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | STRN3 RPS6KA5 ING1 RIPPLY2 ZBTB4 GATA2 PER1 POU5F1 SIX4 RREB1 HDAC7 FZD1 TBX18 ZNF469 SIRT2 ZNF296 MYOZ1 TRIM28 YLPM1 ZBTB10 SIX5 PHF14 TCFL5 WDTC1 | 1.75e-04 | 1413 | 157 | 24 | GO:1902679 |
| GeneOntologyBiologicalProcess | dendrite development | SHANK1 LZTS3 DVL1 CELSR2 ZNF296 TIAM1 HECW2 ANAPC2 PRMT3 MAPK8IP2 | 2.54e-04 | 335 | 157 | 10 | GO:0016358 |
| GeneOntologyCellularComponent | nuclear pore | 9.94e-07 | 101 | 158 | 8 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 8.85e-06 | 18 | 158 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.31e-05 | 8 | 158 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 4.89e-05 | 10 | 158 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.45e-04 | 14 | 158 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.63e-04 | 107 | 158 | 6 | GO:0060076 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.39e-04 | 20 | 158 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 5.10e-04 | 21 | 158 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | asymmetric synapse | SHANK1 LZTS3 DVL1 SHISA9 C1QL1 PRR12 C1QL2 TIAM1 DGKI BSN MAPK8IP2 | 1.03e-03 | 477 | 158 | 11 | GO:0032279 |
| MousePheno | abnormal chest morphology | 1.88e-05 | 39 | 119 | 5 | MP:0004134 | |
| Domain | Cadherin_tail | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8 | 2.01e-11 | 37 | 160 | 9 | PF15974 |
| Domain | Cadherin_CBD | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8 | 2.01e-11 | 37 | 160 | 9 | IPR031904 |
| Domain | Cadherin_C | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8 | 6.94e-11 | 42 | 160 | 9 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8 | 6.94e-11 | 42 | 160 | 9 | PF16492 |
| Domain | Cadherin_CS | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CDHR5 CELSR2 PCDHGA12 PCDHGA8 | 2.40e-09 | 109 | 160 | 11 | IPR020894 |
| Domain | CADHERIN_1 | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CDHR5 CELSR2 PCDHGA12 PCDHGA8 | 3.54e-09 | 113 | 160 | 11 | PS00232 |
| Domain | CADHERIN_2 | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CDHR5 CELSR2 PCDHGA12 PCDHGA8 | 3.89e-09 | 114 | 160 | 11 | PS50268 |
| Domain | - | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CDHR5 CELSR2 PCDHGA12 PCDHGA8 | 3.89e-09 | 114 | 160 | 11 | 2.60.40.60 |
| Domain | Cadherin_2 | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8 | 4.21e-09 | 65 | 160 | 9 | PF08266 |
| Domain | Cadherin_N | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8 | 4.21e-09 | 65 | 160 | 9 | IPR013164 |
| Domain | CA | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CDHR5 CELSR2 PCDHGA12 PCDHGA8 | 4.27e-09 | 115 | 160 | 11 | SM00112 |
| Domain | Cadherin-like | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CDHR5 CELSR2 PCDHGA12 PCDHGA8 | 4.68e-09 | 116 | 160 | 11 | IPR015919 |
| Domain | Cadherin | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CDHR5 CELSR2 PCDHGA12 PCDHGA8 | 5.61e-09 | 118 | 160 | 11 | IPR002126 |
| Domain | Ran_BP1 | 3.27e-08 | 12 | 160 | 5 | PF00638 | |
| Domain | RANBD1 | 3.27e-08 | 12 | 160 | 5 | PS50196 | |
| Domain | Cadherin | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CELSR2 PCDHGA12 PCDHGA8 | 4.68e-08 | 113 | 160 | 10 | PF00028 |
| Domain | RanBD | 5.28e-08 | 13 | 160 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 5.28e-08 | 13 | 160 | 5 | IPR000156 | |
| Domain | GOLGA6L | 7.68e-08 | 6 | 160 | 4 | IPR026737 | |
| Domain | Grip | 1.63e-06 | 11 | 160 | 4 | SM00755 | |
| Domain | GRIP | 1.63e-06 | 11 | 160 | 4 | PF01465 | |
| Domain | GRIP_dom | 2.43e-06 | 12 | 160 | 4 | IPR000237 | |
| Domain | GRIP | 2.43e-06 | 12 | 160 | 4 | PS50913 | |
| Domain | GOLGA2L5 | 1.45e-05 | 18 | 160 | 4 | PF15070 | |
| Domain | Golgin_A | 1.45e-05 | 18 | 160 | 4 | IPR024858 | |
| Domain | Rab_bind | 2.11e-05 | 7 | 160 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 2.11e-05 | 7 | 160 | 3 | IPR032023 | |
| Domain | - | 7.08e-05 | 10 | 160 | 3 | 1.10.220.60 | |
| Domain | ATP-gua_PtransN | 4.33e-04 | 4 | 160 | 2 | PF02807 | |
| Domain | PHOSPHAGEN_KINASE | 4.33e-04 | 4 | 160 | 2 | PS00112 | |
| Domain | ATP-gua_Ptrans | 4.33e-04 | 4 | 160 | 2 | PF00217 | |
| Domain | - | 4.33e-04 | 4 | 160 | 2 | 1.10.135.10 | |
| Domain | ATP-guanido_PTrfase_N | 4.33e-04 | 4 | 160 | 2 | IPR022413 | |
| Domain | ATP-guanido_PTrfase_AS | 4.33e-04 | 4 | 160 | 2 | IPR022415 | |
| Domain | ATP-guanido_PTrfase_cat | 4.33e-04 | 4 | 160 | 2 | IPR022414 | |
| Domain | PHOSPHAGEN_KINASE_N | 4.33e-04 | 4 | 160 | 2 | PS51509 | |
| Domain | PHOSPHAGEN_KINASE_C | 4.33e-04 | 4 | 160 | 2 | PS51510 | |
| Domain | ATP-guanido_PTrfase | 7.17e-04 | 5 | 160 | 2 | IPR000749 | |
| Domain | Gln_synth/guanido_kin_cat_dom | 1.07e-03 | 6 | 160 | 2 | IPR014746 | |
| Domain | RBD | 1.07e-03 | 6 | 160 | 2 | PF02196 | |
| Domain | - | 1.07e-03 | 6 | 160 | 2 | 3.30.590.10 | |
| Domain | PH_dom-like | RGPD2 RANBP3 RGPD1 ARHGEF17 LYST EXOC8 TIAM1 RGPD3 IRS2 MAPK8IP2 RGPD5 | 1.13e-03 | 426 | 160 | 11 | IPR011993 |
| Domain | SIX1_SD | 1.49e-03 | 7 | 160 | 2 | IPR031701 | |
| Domain | RBD | 1.49e-03 | 7 | 160 | 2 | SM00455 | |
| Domain | SIX1_SD | 1.49e-03 | 7 | 160 | 2 | PF16878 | |
| Domain | RBD_dom | 1.49e-03 | 7 | 160 | 2 | IPR003116 | |
| Domain | RBD | 1.49e-03 | 7 | 160 | 2 | PS50898 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CREATINE_PATHWAY | 9.54e-06 | 7 | 93 | 3 | M47940 | |
| Pathway | REACTOME_CREATINE_METABOLISM | 4.41e-05 | 11 | 93 | 3 | M27681 | |
| Pathway | REACTOME_CREATINE_METABOLISM | 4.41e-05 | 11 | 93 | 3 | MM15402 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.35e-04 | 40 | 93 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.49e-04 | 41 | 93 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.64e-04 | 42 | 93 | 4 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.80e-04 | 43 | 93 | 4 | MM14609 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 2.11e-04 | 18 | 93 | 3 | MM1549 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 2.30e-04 | 84 | 93 | 5 | MM14929 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.55e-04 | 47 | 93 | 4 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 3.00e-04 | 49 | 93 | 4 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 3.24e-04 | 50 | 93 | 4 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 3.50e-04 | 51 | 93 | 4 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 4.68e-04 | 55 | 93 | 4 | MM14917 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TNF_P38_SIGNALING_PATHWAY | 5.09e-04 | 24 | 93 | 3 | M47568 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 5.74e-04 | 58 | 93 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 5.74e-04 | 58 | 93 | 4 | MM14736 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 HSPG2 ABCA2 KIAA0513 ZBTB4 NAGLU DVL1 GATA2 PER1 KDM3B RAP1GAP2 CARD10 ANKHD1 ZNF865 BIRC6 LYST HDAC7 KIFC2 RYR1 FZD1 PRR12 SEPHS2 SIRT2 CELSR2 ZNF296 TRIM28 MCM3AP RIPOR1 TNKS1BP1 SH3BP5L IRS2 CRAMP1 ABTB2 ZNF687 | 2.89e-18 | 1105 | 165 | 34 | 35748872 |
| Pubmed | 2.97e-13 | 15 | 165 | 7 | 23515096 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CELSR2 PCDHGA12 PCDHGA8 | 1.83e-12 | 72 | 165 | 10 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CDHR5 PCDHGA12 PCDHGA8 | 2.43e-12 | 74 | 165 | 10 | 10817752 |
| Pubmed | Functional significance of isoform diversification in the protocadherin gamma gene cluster. | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA12 BSN | 3.54e-12 | 34 | 165 | 8 | 22884324 |
| Pubmed | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CELSR2 PCDHGA12 PCDHGA8 | 3.66e-12 | 77 | 165 | 10 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CELSR2 PCDHGA12 PCDHGA8 | 5.43e-12 | 80 | 165 | 10 | 10716726 |
| Pubmed | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA12 BSN | 3.32e-11 | 44 | 165 | 8 | 19029045 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8 | 3.79e-11 | 68 | 165 | 9 | 11230163 |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 5.18e-11 | 28 | 165 | 7 | 15347688 | |
| Pubmed | RGPD2 DVL1 RGPD1 POU5F1 RREB1 ANKHD1 BIRC6 GREB1L PRR12 RGPD3 ZBTB10 TNKS1BP1 IRS2 AKAP1 ZNF687 TANGO6 | 1.90e-10 | 418 | 165 | 16 | 34709266 | |
| Pubmed | RGPD2 STRN3 RANBP3 DVL1 RGPD1 ANKHD1 COL18A1 SIRT2 TRIM28 RGPD3 RGPD5 UBFD1 | 5.64e-10 | 215 | 165 | 12 | 35973513 | |
| Pubmed | RGPD2 STRN3 UNCX PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 RGPD1 DHX57 PSMD3 LYST SEPHS2 PCDHGA12 RGPD3 SCN4A SAP30BP YLPM1 PHF14 BOD1L1 BSN ATP2B3 PCDHGA8 RGPD5 | 5.01e-09 | 1442 | 165 | 26 | 35575683 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.03e-08 | 57 | 165 | 7 | 32633719 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.69e-08 | 7 | 165 | 4 | 15710750 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 14966291 | ||
| Pubmed | SHANK1 RGPD2 STRN3 LZTS3 KIAA0513 OGFR SUN1 DVL1 RGPD1 PER1 PSMD3 TACC2 BIRC6 SHISA9 CELSR2 TRIM28 RGPD3 PDE4DIP DYNC1LI1 BSN | 5.29e-07 | 1139 | 165 | 20 | 36417873 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RANBP3 KDM3B TAB2 BCAR1 N4BP3 ARHGEF17 LYST HDAC7 KSR1 BRAF TIAM1 TNKS1BP1 BOD1L1 SH3BP5L IRS2 AKAP1 ABTB2 | 8.24e-07 | 861 | 165 | 17 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | STRN3 RPS6KA5 KDM3B RREB1 HDAC7 BRAF TRIM28 YLPM1 DYNC1LI1 PHF14 RIPOR1 TNKS1BP1 IRS2 AKAP1 CLUH ZNF687 | 9.75e-07 | 774 | 165 | 16 | 15302935 |
| Pubmed | Two-color in situ hybridization of whole-mount mouse embryos. | 1.04e-06 | 5 | 165 | 3 | 24318811 | |
| Pubmed | The sirtuins promote Dishevelled-1 scaffolding of TIAM1, Rac activation and cell migration. | 1.04e-06 | 5 | 165 | 3 | 24362520 | |
| Pubmed | Isolation and characterization of the gene and cDNA encoding human mitochondrial creatine kinase. | 1.04e-06 | 5 | 165 | 3 | 2914937 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | STRN3 DVL1 PER1 KDM3B RAP1GAP2 TAB2 N4BP3 SOWAHC KSR1 SIRT2 MCM3AP RIPOR1 TNKS1BP1 TNKS IRS2 PRMT3 ABTB2 WDTC1 | 2.42e-06 | 1038 | 165 | 18 | 26673895 |
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 9037092 | ||
| Pubmed | Differential expression of individual gamma-protocadherins during mouse brain development. | 3.62e-06 | 7 | 165 | 3 | 15964765 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 3.62e-06 | 7 | 165 | 3 | 11353387 | |
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 30944974 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 3.62e-06 | 7 | 165 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 3.62e-06 | 7 | 165 | 3 | 17372272 | |
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 38657106 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 21205196 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 18949001 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 25187515 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 8603673 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 26632511 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 24403063 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 10893433 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 23818861 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 23536549 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 12191015 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 22821000 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 20682751 | ||
| Pubmed | SHANK1 RGPD2 STRN3 LZTS3 RGPD1 TPPP ARMCX4 CELSR2 TRIM28 RGPD3 PDE4DIP YLPM1 ZSCAN18 DGKI TNKS BSN MAPK8IP2 | 3.71e-06 | 963 | 165 | 17 | 28671696 | |
| Pubmed | 3.83e-06 | 87 | 165 | 6 | 17979178 | ||
| Pubmed | 5.77e-06 | 8 | 165 | 3 | 26718008 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 5.77e-06 | 8 | 165 | 3 | 21670213 | |
| Pubmed | 5.77e-06 | 8 | 165 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 5.77e-06 | 8 | 165 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 5.77e-06 | 8 | 165 | 3 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 5.77e-06 | 8 | 165 | 3 | 28745977 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXD2 FOXJ2 UNCX ZBTB4 GATA2 GBX1 POU5F1 SIX4 RREB1 TBX18 IRF9 NHLH2 SIX5 CREB3L3 TCFL5 CRAMP1 | 7.44e-06 | 908 | 165 | 16 | 19274049 |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 8.63e-06 | 9 | 165 | 3 | 18394993 | |
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 28100513 | ||
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 17887960 | ||
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 11553612 | ||
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 10601307 | ||
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 9733766 | ||
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 28877029 | ||
| Pubmed | ABCA2 SUN1 KDM3B ADGRV1 NUP58 ANKHD1 HECW2 ANAPC2 TNKS1BP1 BSN CRAMP1 ZNF687 | 9.32e-06 | 529 | 165 | 12 | 14621295 | |
| Pubmed | 1.23e-05 | 10 | 165 | 3 | 17360776 | ||
| Pubmed | Segmental border is defined by Ripply2-mediated Tbx6 repression independent of Mesp2. | 1.23e-05 | 10 | 165 | 3 | 25641698 | |
| Pubmed | 1.23e-05 | 10 | 165 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.23e-05 | 10 | 165 | 3 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.23e-05 | 10 | 165 | 3 | 8857542 | |
| Pubmed | 1.23e-05 | 10 | 165 | 3 | 21859863 | ||
| Pubmed | 1.67e-05 | 233 | 165 | 8 | 37704626 | ||
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 20346937 | ||
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.68e-05 | 11 | 165 | 3 | 35771867 | |
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 34110283 | ||
| Pubmed | Myocardial creatine kinase expression after left ventricular assist device support. | 2.24e-05 | 2 | 165 | 2 | 12039490 | |
| Pubmed | Creatine kinase transcript accumulation: effect of nerve during muscle development. | 2.24e-05 | 2 | 165 | 2 | 10417818 | |
| Pubmed | Creatine kinase activity in normal and Duchenne muscular dystrophy fibroblasts. | 2.24e-05 | 2 | 165 | 2 | 7057800 | |
| Pubmed | Expression of three zebrafish Six4 genes in the cranial sensory placodes and the developing somites. | 2.24e-05 | 2 | 165 | 2 | 11044620 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 19337554 | ||
| Pubmed | Dissimilarity in the folding of human cytosolic creatine kinase isoenzymes. | 2.24e-05 | 2 | 165 | 2 | 21931810 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 9748661 | ||
| Pubmed | Exploring the role of the active site cysteine in human muscle creatine kinase. | 2.24e-05 | 2 | 165 | 2 | 16981706 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 7808454 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 7808458 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21085708 | ||
| Pubmed | Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. | 2.24e-05 | 2 | 165 | 2 | 12514129 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 37511580 | ||
| Pubmed | Diagnostic significance of total creatine kinase and its isoform in tubal ectopic pregnancy. | 2.24e-05 | 2 | 165 | 2 | 23876027 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 37748077 | ||
| Pubmed | ING1 represses transcription by direct DNA binding and through effects on p53. | 2.24e-05 | 2 | 165 | 2 | 14522900 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 2.90e-05 | 13 | 165 | 3 | 31427429 | |
| Pubmed | STRN3 TACC2 BCAR1 SOWAHC ZXDA BRAF TRIM28 ANAPC2 TNKS1BP1 IRS2 ZNF687 | 3.09e-05 | 503 | 165 | 11 | 16964243 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 3.18e-05 | 38 | 165 | 4 | 12791264 | |
| Pubmed | Canonical Wnt signaling regulates smooth muscle precursor development in the mouse ureter. | 3.18e-05 | 38 | 165 | 4 | 22833126 | |
| Pubmed | 3.82e-05 | 130 | 165 | 6 | 12421765 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | STRN3 RANBP3 KDM3B TACC2 ANKHD1 CKB SIRT2 TRIM28 SAP30BP YLPM1 TNKS1BP1 BOD1L1 IRS2 AKAP1 UBFD1 | 4.21e-05 | 934 | 165 | 15 | 33916271 |
| Pubmed | 4.58e-05 | 15 | 165 | 3 | 23671110 | ||
| Pubmed | 4.58e-05 | 15 | 165 | 3 | 14697343 | ||
| Pubmed | SUN1 KDM3B RREB1 BIRC6 SLC4A2 CLPTM1 YLPM1 DYNC1LI1 BOD1L1 SH3BP5L AKAP1 CLUH ZNF687 | 5.16e-05 | 733 | 165 | 13 | 34672954 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | FOXD2 FOXJ2 UNCX GATA2 POU5F1 SIX4 TBX18 IRF9 ZNF296 NHLH2 TCFL5 | 6.26e-05 | 544 | 165 | 11 | 28473536 |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 29259016 | ||
| Pubmed | A cryptic frizzled module in cell surface collagen 18 inhibits Wnt/beta-catenin signaling. | 6.69e-05 | 3 | 165 | 2 | 18382662 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 22510884 | ||
| Interaction | TOP3B interactions | VWA5B2 HSPG2 ABCA2 KIAA0513 ZBTB4 NAGLU DVL1 GATA2 PER1 KDM3B RAP1GAP2 DHX57 CARD10 ANKHD1 ZNF865 BIRC6 LYST HDAC7 KIFC2 RYR1 FZD1 PRR12 SEPHS2 SIRT2 CELSR2 ZNF296 TRIM28 MCM3AP RIPOR1 TNKS1BP1 SH3BP5L IRS2 CRAMP1 ABTB2 ZNF687 | 4.76e-09 | 1470 | 162 | 35 | int:TOP3B |
| Interaction | PCDHGA12 interactions | 7.70e-09 | 10 | 162 | 5 | int:PCDHGA12 | |
| Interaction | PCDHGA4 interactions | 8.54e-09 | 34 | 162 | 7 | int:PCDHGA4 | |
| Interaction | PCDHGA9 interactions | 2.28e-07 | 33 | 162 | 6 | int:PCDHGA9 | |
| Interaction | PCDHGA7 interactions | 1.47e-06 | 25 | 162 | 5 | int:PCDHGA7 | |
| Interaction | H2BC5 interactions | LZTS3 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 BCAR1 ATRIP PCDHGA12 PRMT3 PCDHGA8 | 2.89e-06 | 331 | 162 | 13 | int:H2BC5 |
| Interaction | PCDHGA8 interactions | 5.04e-06 | 5 | 162 | 3 | int:PCDHGA8 | |
| Interaction | RGPD4 interactions | 2.63e-05 | 22 | 162 | 4 | int:RGPD4 | |
| Interaction | PCDHGB2 interactions | 2.66e-05 | 44 | 162 | 5 | int:PCDHGB2 | |
| Interaction | RGPD3 interactions | 3.68e-05 | 47 | 162 | 5 | int:RGPD3 | |
| Interaction | PCDHGA3 interactions | 4.13e-05 | 9 | 162 | 3 | int:PCDHGA3 | |
| Interaction | RGPD1 interactions | 4.52e-05 | 49 | 162 | 5 | int:RGPD1 | |
| Interaction | RGPD2 interactions | 6.11e-05 | 27 | 162 | 4 | int:RGPD2 | |
| Interaction | SDF2L1 interactions | HSPG2 ABCA2 SUN1 NAGLU BCAR1 BIRC6 COL18A1 FUT11 BRAF CLPTM1 WDTC1 | 6.13e-05 | 322 | 162 | 11 | int:SDF2L1 |
| Cytoband | 5q31 | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 KDM3B PCDHGA12 PCDHGA8 | 1.39e-11 | 115 | 164 | 10 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 KDM3B ANKHD1 PCDHGA12 PCDHGA8 | 1.22e-08 | 298 | 164 | 11 | chr5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | SHANK1 ZNF865 RYR1 CKM PRR12 ZNF526 SIRT2 ZNF296 TRIM28 CLPTM1 ZSCAN18 SIX5 NLRP5 | 3.78e-04 | 1192 | 164 | 13 | chr19q13 |
| Cytoband | 15q25.2 | 4.97e-04 | 43 | 164 | 3 | 15q25.2 | |
| GeneFamily | Clustered protocadherins | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8 | 2.36e-10 | 64 | 114 | 9 | 20 |
| GeneFamily | Leucine zipper tumor suppressor family | 2.35e-04 | 4 | 114 | 2 | 1314 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 3.89e-04 | 5 | 114 | 2 | 1157 | |
| GeneFamily | SINE class homeoboxes | 5.81e-04 | 6 | 114 | 2 | 525 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 8.07e-04 | 115 | 114 | 5 | 769 | |
| GeneFamily | Ankyrin repeat domain containing | 8.62e-04 | 242 | 114 | 7 | 403 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN | FOXJ2 PCDHGA9 PCDHGA7 PCDHGA6 TMEM119 LYST COL18A1 PDE4DIP PCDHGA8 | 1.00e-05 | 222 | 161 | 9 | M16955 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | UNCX GATA2 RAP1GAP2 GBX1 C1QL1 C1QL2 XKR7 ZNF296 CACNA1I ATP2B3 HRH3 | 1.15e-05 | 350 | 161 | 11 | M1949 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | UNCX GATA2 RAP1GAP2 GBX1 C1QL1 C1QL2 XKR7 ZNF296 CACNA1I ATP2B3 HRH3 | 1.39e-05 | 357 | 161 | 11 | MM828 |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.62e-07 | 179 | 165 | 8 | be1e09145e24cd40ba51aae1fcd868b4c1e2b4c1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.46e-07 | 184 | 165 | 8 | 629cfed10e1112cf30f6a828ce9efbbc6b207789 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.69e-07 | 190 | 165 | 8 | 2375e604eacd38f61f3e661ba2f76d286fcceca7 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.40e-07 | 193 | 165 | 8 | 8603d1a38955ad2529d04e4704467c73ea5bfbda | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-06 | 168 | 165 | 7 | f45dbcd7753117a3e41e1412bce2100d52fa7fd0 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-06 | 177 | 165 | 7 | c2b8a3a149d70f77612759dea34df9e43953c566 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-06 | 177 | 165 | 7 | 384f841aa7b2d05815af7885e481f5affc55d897 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-06 | 177 | 165 | 7 | 0e9e44119653abfd270e602e5e477a15e774638f | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.63e-06 | 178 | 165 | 7 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.17e-06 | 186 | 165 | 7 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-06 | 194 | 165 | 7 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-06 | 194 | 165 | 7 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-06 | 194 | 165 | 7 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 195 | 165 | 7 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.41e-06 | 195 | 165 | 7 | 80b973d2a23ef9b101c90e1635e68c9a3f78f65d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.91e-06 | 200 | 165 | 7 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 81 | 165 | 5 | 1a22222f2b4ab30f7aa31820029c267a0f2190ec | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 153 | 165 | 6 | c1335e7d7407412431ed4d8c7dfcb2c6086d8483 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.38e-05 | 154 | 165 | 6 | df1b58a20af73fa79c6c069c0117a9ffd85b476f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 160 | 165 | 6 | fe9970c160159b35f6599ed13c89cfb49264d554 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 165 | 165 | 6 | 4cdd80580d5638fd649280ba3893251c2f898f3f | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 165 | 165 | 6 | 36415924d05373e9dd3665be599f4f3f40bf0497 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 165 | 165 | 6 | 56310fddd3d8e4afdfde066d26cee9747e5b8c6a | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 165 | 165 | 6 | c746bb22ef52d7f7fa6ee9c37ae6bbe0ccce718e | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 167 | 165 | 6 | 3c4183a8225bae37b9f5341ebd1b95409ced2022 | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 167 | 165 | 6 | 28e9670586ff551b700c794313d27eedbfa1286b | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.48e-05 | 105 | 165 | 5 | c7528276fee8f6d2cb4639069bc87413b0288025 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.48e-05 | 105 | 165 | 5 | 7bcf3345a21a1ade717128be127e9fe12ae40011 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.48e-05 | 105 | 165 | 5 | 62e89b92bb8c5187ab0205aebd018b4178710bb0 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.57e-05 | 173 | 165 | 6 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.57e-05 | 173 | 165 | 6 | f31e738c2b3b319fb40b0b16b2393a51c9a8999c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.87e-05 | 175 | 165 | 6 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 178 | 165 | 6 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 178 | 165 | 6 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.70e-05 | 180 | 165 | 6 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 182 | 165 | 6 | 75608f80fd570da499891dc02f8649d5428b896c | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 183 | 165 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | MS-matDC|MS / Condition, Cell_class and T cell subcluster | 6.63e-05 | 185 | 165 | 6 | 46bd897349598d85e718e25f9a045d2247723c61 | |
| ToppCell | MS-matDC-|MS / Condition, Cell_class and T cell subcluster | 6.63e-05 | 185 | 165 | 6 | 9fbe70d3a7b106fb31e13b7f95029785f28ca6f4 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.83e-05 | 186 | 165 | 6 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.83e-05 | 186 | 165 | 6 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.04e-05 | 187 | 165 | 6 | 98477ba04a42a8da80a72f41a182429f46283595 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Basophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.25e-05 | 188 | 165 | 6 | 3638d85452de15a060146628fbbad9d2a36feb13 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.46e-05 | 189 | 165 | 6 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.68e-05 | 190 | 165 | 6 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.68e-05 | 190 | 165 | 6 | b5c6f3248c0c2f648e1578457c6a729ca22bf0da | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.91e-05 | 191 | 165 | 6 | 19832ddd559a353e1618fe853d79e3edfec6dcda | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.91e-05 | 191 | 165 | 6 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 8.62e-05 | 194 | 165 | 6 | b6488bc3a8905e926ad298332963e1bbaf010046 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 8.62e-05 | 194 | 165 | 6 | 1e1f4139ad584f493d75a9b7f1568eca4653c5a2 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.62e-05 | 194 | 165 | 6 | aaecde88bd54134a938e76cdf059c1c2653e4e77 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.62e-05 | 194 | 165 | 6 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.86e-05 | 195 | 165 | 6 | 6a0460d949ccda7c9fe76870d3ee6c2f60677d61 | |
| ToppCell | droplet-Marrow-BM-1m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-05 | 195 | 165 | 6 | 637b06ef3967b03f7165d102d316e8b7161a817d | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.11e-05 | 196 | 165 | 6 | 4740ef6e428f1ccc81fc98c3b868afd38ce60535 | |
| ToppCell | T_cells-Treg_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 9.37e-05 | 197 | 165 | 6 | ec9398ae3577f61d6b1e6aba50ef4261aaaa7610 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.64e-05 | 198 | 165 | 6 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.64e-05 | 198 | 165 | 6 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.64e-05 | 198 | 165 | 6 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.64e-05 | 198 | 165 | 6 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-dn_T|URO / Disease, condition lineage and cell class | 1.02e-04 | 200 | 165 | 6 | 04ea6381b93a5d8bbeda4d71c788d7fbac6d40bc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 165 | 6 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-dn_T|IIF / Disease, condition lineage and cell class | 1.02e-04 | 200 | 165 | 6 | c34fff02992cba6bcc2308019cb00b94e1227300 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 165 | 6 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.37e-04 | 133 | 165 | 5 | 63d2f096ae47d9b587acc6c5fbd346e5e58842b8 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.42e-04 | 134 | 165 | 5 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| Drug | BIIB513 | 2.88e-07 | 9 | 160 | 4 | CID006918374 | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A | 1.10e-06 | 192 | 160 | 10 | 4395_DN | |
| Drug | Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.20e-06 | 194 | 160 | 10 | 7354_DN | |
| Drug | ATP gamma-(N-(2-chloroethyl)-N-methyl)amide | 3.37e-06 | 5 | 160 | 3 | CID000174813 | |
| Drug | epoxycreatine | 3.37e-06 | 5 | 160 | 3 | CID000194341 | |
| Drug | gamma-benzylamide ATP | 3.37e-06 | 5 | 160 | 3 | CID000194049 | |
| Drug | vitamin K1 diacetate | 3.37e-06 | 5 | 160 | 3 | CID006441272 | |
| Drug | ATP gamma-p-azidoanilide | 3.37e-06 | 5 | 160 | 3 | CID003035480 | |
| Drug | homocyclocreatine | 3.37e-06 | 5 | 160 | 3 | CID000128636 | |
| Drug | N-2-hydroxyethyl-N-methyl-gamma-amide ATP | 3.37e-06 | 5 | 160 | 3 | CID000195952 | |
| Drug | steroid U | 3.37e-06 | 5 | 160 | 3 | CID000133659 | |
| Drug | gamma-anilide ATP | 3.37e-06 | 5 | 160 | 3 | CID000193883 | |
| Drug | trimetazidine | 3.80e-06 | 34 | 160 | 5 | CID000021109 | |
| Drug | DSLET | 4.41e-06 | 35 | 160 | 5 | CID000107847 | |
| Drug | phosphocyclocreatine | 6.71e-06 | 6 | 160 | 3 | CID000124896 | |
| Drug | Creatine | 6.71e-06 | 6 | 160 | 3 | DB00148 | |
| Drug | CoADP | 6.71e-06 | 6 | 160 | 3 | CID000194171 | |
| Drug | PTMSA | 6.71e-06 | 6 | 160 | 3 | CID000006934 | |
| Drug | hexahydro-4-methyl phthalic anhydride | 6.71e-06 | 6 | 160 | 3 | CID000086876 | |
| Drug | CID9959010 | 7.64e-06 | 39 | 160 | 5 | CID009959010 | |
| Drug | montmorillonite | 8.68e-06 | 40 | 160 | 5 | CID000517273 | |
| Drug | Ceforanide [60925-61-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 9.39e-06 | 193 | 160 | 9 | 5351_UP | |
| Drug | Nialamide [51-12-7]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.06e-05 | 196 | 160 | 9 | 3790_DN | |
| Drug | Alprostadil [745-65-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.11e-05 | 197 | 160 | 9 | 7358_DN | |
| Drug | gemcadiol | 1.17e-05 | 7 | 160 | 3 | CID000037147 | |
| Drug | AC1L1YAP | 1.17e-05 | 7 | 160 | 3 | CID000063066 | |
| Drug | 2-nitrobenzenesulphonyl fluoride | 1.17e-05 | 7 | 160 | 3 | CID000097375 | |
| Drug | 1-carboxymethyl-2-iminohexahydropyrimidine | 1.17e-05 | 7 | 160 | 3 | CID000193725 | |
| Drug | Piretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.20e-05 | 199 | 160 | 9 | 6828_UP | |
| Drug | Norcyclobenzaprine [303-50-4]; Up 200; 15.4uM; HL60; HT_HG-U133A | 1.20e-05 | 199 | 160 | 9 | 2469_UP | |
| Drug | Cu-cyclam | 1.25e-05 | 43 | 160 | 5 | CID000467374 | |
| Drug | Rh(H2O)4PP | 1.86e-05 | 8 | 160 | 3 | CID000194736 | |
| Drug | Deltakephalin | 2.24e-05 | 24 | 160 | 4 | CID000119319 | |
| Drug | lactofen | 2.30e-05 | 81 | 160 | 6 | CID000062276 | |
| Drug | thallium | 2.65e-05 | 25 | 160 | 4 | CID000105005 | |
| Drug | lombricine | 2.77e-05 | 9 | 160 | 3 | CID000159847 | |
| Drug | bepridil | 3.11e-05 | 126 | 160 | 7 | CID000002351 | |
| Drug | Marathon | 3.52e-05 | 53 | 160 | 5 | CID000034469 | |
| Drug | pyridinophane cryptand | 3.94e-05 | 10 | 160 | 3 | CID006454246 | |
| Drug | ONO-3144 | 3.94e-05 | 10 | 160 | 3 | CID000166446 | |
| Drug | AC1L4VLE | 5.39e-05 | 11 | 160 | 3 | CID000193097 | |
| Drug | stannous pyrophosphate | 5.39e-05 | 11 | 160 | 3 | CID000066379 | |
| Drug | ethylmalonic acid | 5.58e-05 | 30 | 160 | 4 | CID000011756 | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A | 5.92e-05 | 189 | 160 | 8 | 3084_UP | |
| Drug | M-HN | 6.37e-05 | 31 | 160 | 4 | CID000015450 | |
| Drug | Piperacetazine [3819-00-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 6.37e-05 | 191 | 160 | 8 | 3574_UP | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 6.86e-05 | 193 | 160 | 8 | 3908_DN | |
| Drug | prazosin hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 7.11e-05 | 194 | 160 | 8 | 942_UP | |
| Drug | nicotinoylprocaine | 7.15e-05 | 12 | 160 | 3 | CID000159667 | |
| Drug | themisone | 7.15e-05 | 12 | 160 | 3 | CID000016235 | |
| Drug | danshenxinkun A | 7.15e-05 | 12 | 160 | 3 | CID000149138 | |
| Drug | Dhga | 7.15e-05 | 12 | 160 | 3 | CID000467478 | |
| Drug | AC1NSVWC | 7.15e-05 | 12 | 160 | 3 | CID005317648 | |
| Drug | Securinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 7.37e-05 | 195 | 160 | 8 | 3470_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HG-U133A | 7.64e-05 | 196 | 160 | 8 | 1958_UP | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.64e-05 | 196 | 160 | 8 | 4965_DN | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; HL60; HT_HG-U133A | 7.64e-05 | 196 | 160 | 8 | 2179_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 3415_DN | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; PC3; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 3989_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 3277_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 3456_DN | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 6353_DN | |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 6668_DN | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 7417_DN | |
| Drug | Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; PC3; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 3676_DN | |
| Drug | (-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; HL60; HG-U133A | 8.49e-05 | 199 | 160 | 8 | 1780_UP | |
| Drug | Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 8.49e-05 | 199 | 160 | 8 | 7203_DN | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; MCF7; HT_HG-U133A | 8.49e-05 | 199 | 160 | 8 | 6496_DN | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; PC3; HG-U133A | 8.80e-05 | 200 | 160 | 8 | 1939_UP | |
| Drug | yttria | 9.25e-05 | 13 | 160 | 3 | CID000159374 | |
| Drug | AC1L1CQC | 9.46e-05 | 65 | 160 | 5 | CID000002012 | |
| Drug | carboxyatractyloside | 1.16e-04 | 36 | 160 | 4 | CID000036403 | |
| Drug | 2-chloromercuri-4-nitrophenol | 1.17e-04 | 14 | 160 | 3 | CID000090545 | |
| Drug | bisoprolol | 1.29e-04 | 37 | 160 | 4 | CID000002405 | |
| Drug | propionyl-L-carnitine | 1.44e-04 | 38 | 160 | 4 | CID000107738 | |
| Drug | g-eq | 1.46e-04 | 15 | 160 | 3 | CID000447767 | |
| Drug | taurocyamine | 1.46e-04 | 15 | 160 | 3 | CID000068340 | |
| Drug | calcium dobesilate | 1.78e-04 | 16 | 160 | 3 | CID000017507 | |
| Drug | M-Hb | 2.12e-04 | 77 | 160 | 5 | CID006122542 | |
| Drug | hippuryl-L-lysine | 2.15e-04 | 17 | 160 | 3 | CID000098208 | |
| Drug | L-640,035 | 2.15e-04 | 17 | 160 | 3 | CID000127538 | |
| Drug | AC1MOE8Y | 2.25e-04 | 78 | 160 | 5 | CID003342293 | |
| Disease | mental development measurement | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA8 | 4.60e-13 | 25 | 154 | 8 | EFO_0008230 |
| Disease | Sarcosine measurement | 2.10e-11 | 23 | 154 | 7 | EFO_0021668 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8 | 1.28e-10 | 71 | 154 | 9 | EFO_0007878, EFO_0007979 |
| Disease | Congenital myopathy (disorder) | 2.96e-05 | 12 | 154 | 3 | C0270960 | |
| Disease | mean platelet volume | STRN3 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 POU5F1 APOBR HDAC7 PCDHGA12 ZBTB10 RIPOR1 IRS2 PCDHGA8 | 9.14e-05 | 1020 | 154 | 16 | EFO_0004584 |
| Disease | lymphocyte count | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 GATA2 RAP1GAP2 PSMD3 POU5F1 RREB1 LYST HDAC7 ZNF469 PCDHGA12 MCM3AP RIPOR1 PCDHGA8 | 2.35e-04 | 1464 | 154 | 19 | EFO_0004587 |
| Disease | myotonic dystrophy type 1 (implicated_via_orthology) | 4.00e-04 | 6 | 154 | 2 | DOID:11722 (implicated_via_orthology) | |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 5.59e-04 | 7 | 154 | 2 | DOID:14702 (implicated_via_orthology) | |
| Disease | catalase measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0008071 | |
| Disease | Developmental Coordination Disorder | 7.42e-04 | 8 | 154 | 2 | C0011757 | |
| Disease | Motor Skills Disorders | 7.42e-04 | 8 | 154 | 2 | C0026613 | |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0008309 | |
| Disease | amnestic disorder (implicated_via_orthology) | 9.51e-04 | 9 | 154 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | aplastic anemia (is_marker_for) | 9.51e-04 | 9 | 154 | 2 | DOID:12449 (is_marker_for) | |
| Disease | opioid dependence | 1.58e-03 | 237 | 154 | 6 | EFO_0005611 | |
| Disease | alcohol and nicotine codependence | 2.03e-03 | 13 | 154 | 2 | EFO_0004776 | |
| Disease | creatinine measurement | CERS2 UNCX OGFR TPPP CARD10 GOLPH3 ADGRV1 RREB1 BIRC6 RYR1 COL18A1 CELSR2 BSN | 2.22e-03 | 995 | 154 | 13 | EFO_0004518 |
| Disease | Antithrombotic agent use measurement | 3.00e-03 | 55 | 154 | 3 | EFO_0009925 | |
| Disease | Abnormal behavior | 3.10e-03 | 16 | 154 | 2 | C0233514 | |
| Disease | Alzheimer disease, polygenic risk score | PCDHGB1 PCDHGA4 PCDHGA3 PCDHGA2 TACC2 ZSWIM6 CKM CLPTM1 TNKS1BP1 | 3.77e-03 | 586 | 154 | 9 | EFO_0030082, MONDO_0004975 |
| Disease | Congenital Fiber Type Disproportion | 3.92e-03 | 18 | 154 | 2 | C0546264 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 4.07e-03 | 200 | 154 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | apolipoprotein A 1 measurement | CERS2 IRF9 COL18A1 CELSR2 CLPTM1 YLPM1 RIPOR1 TNKS1BP1 ACAA2 CREB3L3 TANGO6 | 5.06e-03 | 848 | 154 | 11 | EFO_0004614 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGSGAYEDVAGGAQT | 421 | Q99952 | |
| GEAEGGVAVSDVGES | 931 | Q5RHP9 | |
| GSEGQEAATGSGDGR | 1451 | Q5RHP9 | |
| EAATGSGDGRQETGA | 1456 | Q5RHP9 | |
| EAGAGAGAAASSAAD | 26 | P15056 | |
| AEAVAVASGTAGGDD | 201 | P04920 | |
| ARETGGAEGTGDAVL | 196 | Q92667 | |
| EAGEAEEEAGAGSGS | 6 | Q9BWT7 | |
| GLTGDSDGTGDLAVE | 441 | Q9UJX6 | |
| EGTVGDDVGATAGDS | 2431 | Q9NR09 | |
| GGGGSEEVEVQFSAG | 21 | Q8N4J0 | |
| STGSGRAGLEAAGDE | 446 | Q68CJ9 | |
| SGIEGAEGAGLEEGS | 306 | Q7L8J4 | |
| ALDAGRGGSGATLED | 561 | P56945 | |
| GLAGGTTSAADGLDG | 356 | Q5FYB1 | |
| AELFRVDGSGSGDGD | 1816 | Q8WXG9 | |
| ETSGAGGESQVGAAT | 1176 | Q96L96 | |
| DDGASVLFEAAGGGN | 241 | Q8WXK1 | |
| GAGARTDGGDALSEQ | 41 | O75973 | |
| SDADLADGVSGGEGK | 91 | P14209 | |
| GGDDGDGDFIVESTS | 856 | Q9HCU4 | |
| LDVDGASDSGSGDEG | 811 | Q9HBB8 | |
| TESSEGEEAAAGGGA | 346 | Q96G23 | |
| AEAGAGAGAEAGAEA | 1821 | Q5H9R4 | |
| GEESEACGNVSGGAE | 131 | Q16720 | |
| AGAGGAAGDEAREAA | 16 | P54802 | |
| TAAGAGDEGDGQTTG | 551 | Q9H6Z4 | |
| ASEAADGSSTLGGGA | 856 | Q9Y5G6 | |
| ASEAADGSSTLGGGA | 856 | Q9Y5H1 | |
| ADSISGDDLGSGDLG | 61 | P98160 | |
| TEEENKGSGTGAAGA | 1216 | Q99666 | |
| ASEAADGSSTLGGGA | 856 | Q9Y5G5 | |
| ASEAADGSSTLGGGA | 856 | O60330 | |
| LQDGDGSLGDGASES | 31 | O60268 | |
| GSGGSELSNGEAGEA | 716 | Q96PE2 | |
| EEGSAGEAQGTCEGA | 756 | Q9P2P5 | |
| TCEGATAQEEGATGG | 766 | Q9P2P5 | |
| ASEAADGSSTLGGGA | 886 | Q9Y5G9 | |
| ASEAADGSSTLGGGA | 856 | Q9Y5G7 | |
| VSVDGEAEAGGESGT | 556 | O60299 | |
| GTGGVDTAAVGGVFD | 321 | P12277 | |
| EDGGHDTCVAGAAGS | 396 | Q9NVR5 | |
| GDEGSVDDTSSDAGG | 1391 | O60318 | |
| GGEASEEEAGAALLG | 541 | Q13387 | |
| EGGSAEATDGSGTLQ | 911 | Q9UPA5 | |
| ASGNGGAAAGDDEDG | 31 | Q9Y6G9 | |
| IDSSEAEAGAARGGA | 1101 | O15534 | |
| GEAGATGEAGAAGEA | 146 | A0A0J9YXQ4 | |
| RAAGEAGAAGEAGAV | 251 | A0A0J9YXQ4 | |
| AGSVGEAGGVNEERS | 126 | A0A0J9YX94 | |
| GDAAAAEGGAGAAAS | 21 | Q8IVT5 | |
| ASEAADGSSTLGGGA | 856 | Q9Y5G4 | |
| ASEAADGSSTLGGGA | 851 | Q9Y5G3 | |
| GASGDSGSGLGDARE | 661 | P39060 | |
| RGEVDSNGSDGGEAS | 306 | Q7LBC6 | |
| ETGGEAAGAGEADVG | 546 | Q8N9W4 | |
| EADVGAGGEDAGSGA | 556 | Q8N9W4 | |
| AVGTGEAAGGAGEAA | 401 | A6NEM1 | |
| AVGTGEAAGGAEEAA | 491 | A6NI86 | |
| SGEAVGTGEAAGGAE | 516 | H0YKK7 | |
| MEEEGGSSGGAAGTS | 1 | O75582 | |
| AAGTSADGGDGGEQL | 11 | O75582 | |
| EGATAAETEEQGHGG | 216 | P59047 | |
| VDGGAVAAGASGRES | 211 | Q9P0K8 | |
| AAGAAAASGGEEGVG | 111 | Q8IYI6 | |
| DEGVSASSAGAGAGE | 1166 | Q9C091 | |
| FKVGDASDSEGSGNG | 31 | O94880 | |
| EGEAGVGVESNSDGA | 96 | Q01860 | |
| ASEAADGSSTLGGGA | 856 | Q9Y5H0 | |
| VRTASEGDGGAAAGA | 361 | Q9Y4H2 | |
| VAEEENKGSGTGAAG | 1216 | A6NKT7 | |
| EGDGSVNDGTEGESA | 1776 | Q8NFC6 | |
| LSARLAEEGSGDAGG | 26 | Q9UP38 | |
| SSAGGSAARGEDKDG | 196 | P23769 | |
| AQRAVSEASGAGSGG | 21 | A4D1B5 | |
| SEASGAGSGGADVLE | 26 | A4D1B5 | |
| AASGEGSAAGDLDAA | 396 | Q8WWV6 | |
| GSAAGDLDAATGDRG | 401 | Q8WWV6 | |
| GDSEDDGFLDSSAGG | 211 | Q14549 | |
| AGVGGDSEGEVTSAL | 136 | Q7Z5L3 | |
| SGATGGRGAVENEED | 6 | O60678 | |
| GAGSAAAAGAAALDE | 91 | O75912 | |
| ASGHGSVAEREAGGE | 21 | Q495W5 | |
| GGDGVLDATGEEANS | 1191 | Q6P158 | |
| SSAGGEDEADGDGAR | 581 | Q9P0X4 | |
| DGTNGGASEAGEDRE | 46 | B0YJ81 | |
| ESLEGEGAGGADAAE | 26 | Q96RY5 | |
| EGAGGADAAEESSGT | 31 | Q96RY5 | |
| ERAAGGGAGSSEDDA | 26 | Q9H4A6 | |
| TGDESTTGGEAFVNG | 2101 | Q9BZC7 | |
| GDIATVCDSAGGGSD | 3671 | Q99698 | |
| GVGEAAVGAEAGEAT | 276 | Q9Y5N1 | |
| EEEGASGGAVHSDIG | 166 | Q00978 | |
| GGDTRDGGFLNDAST | 51 | A6NGE4 | |
| ERRAAGAGGSGSESD | 591 | O14640 | |
| LLSGVGADSAAGEGN | 496 | Q8WXE1 | |
| SGAVDEVGAGSGEGF | 741 | Q8WUI4 | |
| ESESGESEGCQAVGG | 306 | D6RIA3 | |
| GAEGAEEGAAGLEGT | 4271 | P21817 | |
| EEGAAGLEGTAATAA | 4276 | P21817 | |
| EGASEGAGDAAEGAG | 4406 | P21817 | |
| DGSEGAAEGRAAAVS | 66 | Q96AC6 | |
| GGVDTAATGGVFDIS | 356 | P12532 | |
| AQGGIAEAAFAGEDG | 186 | Q8WUT4 | |
| TAGEVAGDTGGDTVG | 386 | O43193 | |
| AATSTAGNEGLGGID | 206 | Q9BVL2 | |
| TEEENKGSGTGAAGA | 1201 | P0DJD0 | |
| DVNEEGTEAAAGTGG | 361 | P05120 | |
| VDEGAGDSAAVASGG | 461 | Q9NZT2 | |
| SEADADIDVVGGGSG | 21 | O60548 | |
| AEDGEGAGEARSSGD | 311 | Q13033 | |
| STAGEGEAMEEGDSG | 646 | Q684P5 | |
| LSLGEADGAGEAGEA | 856 | P35499 | |
| GEGDLNFSDDSGISG | 56 | Q9NYJ8 | |
| GTGGVDTAAVGSVFD | 321 | P06732 | |
| EENKGSGTGAAGASD | 1211 | P0DJD1 | |
| ELGDTAGNSGKAGAD | 261 | Q9UK53 | |
| VEEAEGDGKGGSRAA | 41 | Q02577 | |
| GDAATAAARVSGEEG | 56 | Q9UIU6 | |
| SGEEGAVAAAAAGAA | 66 | Q9UIU6 | |
| AAEGEAAAAAGAGAG | 41 | Q8N196 | |
| RSGAASGEASEGAEA | 46 | B4DS77 | |
| QDSDSDSEGGAAGGE | 21 | Q8IXJ6 | |
| ALDEGDGESAAGSGG | 396 | Q53LP3 | |
| SGADGLVGEDGAADA | 656 | Q9ULL5 | |
| LFLSTDAGDEDGGDG | 1256 | Q9Y566 | |
| DERGTEGAAGTGAQT | 361 | Q8IW75 | |
| GAHVEGSAVNGGEDS | 591 | Q8N961 | |
| VVGAGSGEDNRSSAG | 56 | P25100 | |
| GGGGTSFEEDLDSVA | 6 | Q8IWZ3 | |
| ETASGGEEAETASGG | 311 | Q0VD83 | |
| TASGGEEAGTASGGE | 321 | Q0VD83 | |
| EEAGTASGGEEAGIA | 326 | Q0VD83 | |
| ASGGEEAGIASGGEA | 331 | Q0VD83 | |
| EAGIASGGEAGTASG | 336 | Q0VD83 | |
| GEEAGTASGGEEAGT | 351 | Q0VD83 | |
| ADAGTGETARAAGGS | 6 | Q7Z624 | |
| EADGARSAVVAAGGG | 6 | O96005 | |
| EAGSEEEGSSASGLA | 661 | O75153 | |
| TAGNASGVADGAGAV | 246 | P42765 | |
| ITGLSSGGAGASDDE | 651 | Q8N5D0 | |
| SGGAGASDDEDSSEG | 656 | Q8N5D0 | |
| DAAEEGGTAVTGGQT | 201 | Q99611 | |
| AAQASVSNGEDAGGG | 66 | O14562 | |
| VAALAGVSGGEDAGG | 761 | P0CJ78 | |
| GLELASDGGAVEEGA | 961 | Q5TCY1 | |
| GAERDGASAGERAGT | 481 | Q5GH72 | |
| GSTGEADGKTAAAAA | 46 | O43242 | |
| GEGSEFADSGIEGAT | 326 | Q13009 | |
| EGDGEAGAGGAASQE | 1376 | Q92766 | |
| AGEKGSSEGDEGAAL | 61 | O95935 | |
| GVGDGDEDTDSAIGS | 881 | Q5VZP5 | |
| GAEGTESGAAACAAT | 6 | Q5TAB7 | |
| ELAVGGASNAGDGAA | 1001 | O95271 | |
| VGSGGSSEARESAVG | 1176 | Q9C0C2 | |
| SAAGGGGSEAAGAEQ | 16 | O75896 | |
| GAGAAGGSDAEVTAA | 331 | Q9C0B7 | |
| GGSLETVAEGGASQD | 51 | Q9UJ04 | |
| AGGGSTAAEEASETA | 831 | Q9P1Z0 | |
| EAGAAETGGSAGAGD | 1126 | O95359 | |
| GKVAGAAGEAEGDIT | 1696 | O95359 | |
| AGIEAVGSAAEEKGG | 26 | Q9UHR5 | |
| GSDASLDSDQGLGGV | 1431 | P49750 | |
| KDLDSGGAAEGSGSG | 956 | Q96JG9 | |
| GVEVAAGASSGGETR | 131 | Q969Z4 | |
| SDTEASEGAEGLGGT | 1146 | Q8N398 | |
| LSLESEGAGEGAAAS | 31 | O94811 | |
| VGAAGAADGGDETRL | 191 | Q9HCJ5 | |
| VGGDVETAGSGQAAG | 96 | P98168 | |
| DGDGQSLEGVSSSGD | 376 | Q8TBC5 | |
| EVGDDAVGGDESTAG | 256 | Q8TF50 | |
| GVGSESEDTAAASAG | 46 | Q8N1G0 | |
| EALAGGSAGDGAQAA | 96 | Q8N1G0 | |
| GSAGDGAQAAGVTKE | 101 | Q8N1G0 | |
| LAEAGTSQDGGDAGT | 641 | Q96DT7 | |
| GDGEAVGADSGTSSA | 66 | O94901 | |
| TSAAVAASDGDGDAG | 1406 | P52746 | |
| AGGSGDRSLEEALGA | 786 | Q6ZS17 | |
| EDVAGSGEAEGSSAS | 36 | Q4V9L6 | |
| EAGAAEKTSGGGDGA | 136 | Q9UL49 | |
| NSSGDGGAAGDGTVV | 101 | Q13263 | |
| RDLASAAATEGGGGD | 461 | A6NJT0 | |
| GGEGAGAAATAGVQE | 321 | Q8WUU4 | |
| GLLGEAGGSEARDSA | 451 | O15049 | |
| AIGGAAAGDDTEDTS | 936 | Q5VU43 | |
| AAGTAGVGETGSGDQ | 156 | Q9NP98 |